Previous studies have found that LHX6 modulated the carcinogenicity of breast cancer cells via β-catenin/TCF4 complex [19], we thus speculated that LHX9 might have the similar regulatory function on OS through β-catenin/TCF4 since it was the homologue of LHX6. The gene discussed is TCF4; the disease is breast cancer.